Navigation Links
Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA
Date:9/13/2010

erentiates it as a true second generation oxazolidinone which may be a solution to emerging linezolid resistance."

The AAC manuscripts are available to subscribers ahead of print at: http://aac.asm.org/papbyrecent.dtl.

Structure-Activity Relationships of Diverse Oxazolidinones for Linezolid-Resistant Staphylococcus aureus Strains Possessing the cfr Methyltransferase Gene or Ribosomal  Mutations

Jeffrey B. Locke, John Finn, Mark Hilgers, Gracia Morales, Shahad Rahawi, Kedar GC, Juan Jose Picazo, Weonbin Im, Karen Joy Shaw, and Jeffrey L. Stein

Antimicrob. Agents Chemother. published ahead of print on 13 September 2010

Elevated Linezolid Resistance in Clinical Staphylococcus aureus cfr Isolates is Associated with Co-occurring Mutations in Ribosomal Protein L3

Jeffrey B. Locke, Gracia Morales, Mark Hilgers, Kedar GC, Shahad Rahawi, Juan José Picazo, Karen Joy Shaw, and Jeffrey L. Stein

Antimicrob. Agents Chemother. published ahead of print on 13 September 2010

The results in these AAC articles are also featured in two poster presentations given at this year's ICAAC conference on September 14 (posters C1-1431 and C1-1432; Session 170; 11:15AM – 1:15PM). Trius presented a total of 12 posters at ICAAC highlighting the latest findings from its antibiotic research programs, including preclinical research on antibiotics targeting Gyrase B/ParE and dihydrofolate reductase (DHFR). Copies of all posters are available on the Trius website at: http://www.triusrx.com/trius-therapeutics-news-posters-publications-year.php.  

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Refor
'/>"/>

SOURCE Trius Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trius to Present at the Stifel Nicolaus Healthcare Conference
2. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
3. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
4. Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
5. Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
6. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
7. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
8. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
9. Trius Doses First Patient in Antibacterial Phase 2 Trial
10. PacificGMP Completes GMP Product Fill for Trius Therapeutics
11. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) ... of Advaxis, Inc. ("Advaxis" or the "Company") (NASDAQ: ... its fiduciary duties to shareholders. On January ... website reporting that Advaxis had misrepresented the clinical data ...
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... , Jan. 23, 2015  iMD Companies, Inc. (ICBU) has repositioned ... market share and grab a foothold in the hydroponic, hemp ... capabilities and a presence in the sector, and recently partnering ... growth of hemp and medical marijuana, iMD is committing to ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2
... N.J. and LACHEN, Switzerland, Sept. 26, 2011 ... largest human protein products manufacturers in the world, has ... efficacy and safety of wilate® (von Willebrand ... post-operative bleeding in pediatric and adult patients with Type ...
... Accuray Incorporated (Nasdaq: ARAY ), the premier ... to present at the JMP Securities Healthcare Conference in New ... a.m. PDT. A live webcast of the presentation ... the Company,s website at http://www.accuray.com . The webcast replay ...
Cached Medicine Technology:Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 2Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients 3
(Date:1/22/2015)... Glendale, AZ (PRWEB) January 22, 2015 Padre ... a long supporter of Pro Player Health Alliance ... with Padre Murphy's in getting everyone, including NFL greats, treated ... one of the leading groups supporting the cause in the ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, ... dresses. View website of AngelWeddingDress.com to find ... wedding dresses online for a bridal party. AngelWeddingDress offers ... for them. Its maternity wedding dresses are specially designed ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the ... . , Auto insurance quotes help many drivers find ... necessary to call an agent or visit an agency for ... single website: http://autocarinsurancebest.com/ . , Every business who relies ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
(Date:1/22/2015)... Mass. (PRWEB) January 22, 2015 EBSCO ... (AMA) are expanding their relationship in an effort to ... around the world. While EBSCO has long made AMA journals ... a sales agent for The JAMA Network. , ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... Jan. 16 John T. Gribbin of Clarksburg, president ... was installed as chairman of the board of the ... The chairman,s official installation, as well as the appointment ... Annual Meeting at the Hyatt Regency Princeton. "Here in ...
... 16 The Endovascular Forum, Inc. (EVF), an ... of Interventional Radiology (SIR) announce a collaboration that ... Communities of Practice (CoP) goals of reconstructing clinical ... to enhance clinical performance and diagnostic and procedural ...
... Inc. (LPI) announced today that it has received ... Application (ANDA) for Levetiracetam Tablets 250mg, 500mg, 750mg ... Administration (USFDA). Commercial shipments of the product ... equivalent of UCB Pharmaceuticals, Keppra(R) tablets, indicated as ...
... Lung Cancer Partnership is pleased to announce I-Ching Wang, ... of the 2009 Career Development Award. , The $80,000 grant ... develop their careers in lung cancer research. , ... protein that binds to specific parts of DNA and plays ...
... health insurance market increasingly becomes consumer-driven, BlueCross BlueShield of ... insurance with face-to-face assistance at the company,s first retail ... Mount Pleasant, S.C.Located at 615 Johnnie Dodds Blvd., Suite ... the 1,800 square foot SC BlueStore(SM) will ...
... Ind., Jan. 16 Hill-Rom Holdings,Inc.,s, (NYSE: HRC ... February 4, 2009. You are invited to participate in ... a.m. EST. , Earnings Release: ... ended December 31, 2008 will be released to the public,after ...
Cached Medicine News:Health News:Hospital Association Names New Chairman, Appoints Board Officers and New Members 2Health News:The Endovascular Forum, Inc. and the Society of Interventional Radiology Partner to Extend the Clinical Influence of Electronic Medical Care Advancement Through Communities of Practice Designed to Deepen the Conversation of Clinical Experience and Advance 2Health News:The Endovascular Forum, Inc. and the Society of Interventional Radiology Partner to Extend the Clinical Influence of Electronic Medical Care Advancement Through Communities of Practice Designed to Deepen the Conversation of Clinical Experience and Advance 3Health News:The Endovascular Forum, Inc. and the Society of Interventional Radiology Partner to Extend the Clinical Influence of Electronic Medical Care Advancement Through Communities of Practice Designed to Deepen the Conversation of Clinical Experience and Advance 4Health News:Lupin is Granted USFDA Approval for Levetiracetam Tablets 2Health News:S.C. BlueCross to Open Its First Health Insurance Retail Store 2Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast 2